In late December, Dr. Christopher R. Martens and his team at the University of Delaware published results of a study using NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes). The title of their paper is “Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin“. You can read it HERE. Earlier this week, Dr. Martens was interviewed by MedicalResearch.com wherein he discussed his findings. Here are some excerpts:

From MedicalResearch.com‘s interview with Dr. Martens:

“One of the main issues with Alzheimer’s disease is an impaired ability to make energy in the brain. NAD+ is critically involved in the creation of energy within cells and there is strong evidence that nicotinamide riboside (NR), a precursor to NAD+, can restore brain function in mice that exhibit similar characteristics as people with Alzheimer’s disease.

…Our results suggest that NR is capable of raising NAD+ and altering the metabolism of important molecular markers of Alzheimer’s disease. Our findings don’t necessarily mean that the supplement will lower these biomarkers or reverse any of the symptoms of Alzheimer’s disease. We view as initial evidence that the supplement can reach our intended target and as validation that we should continue studying its effects in people with cognitive impairment”

You can read the entire interview HERE.

NOTE:

  • Video: First Human Trial Shows NR Can Enter The Brain And Reduces Biomarker For Alzheimer’s (Link)
  • Nicotinamide Riboside “NR” for Alzheimer’s (FAQs)
  • Nicotinamide Riboside “NR” (FAQs) (Consumer Reviews)

FOLLOW us on Twitter @RaisingNAD